Trials / Unknown
UnknownNCT03932149
The Effect of Intermittent Theta Burst Stimulation (iTBS) in Patients With Alcohol Use Disorder
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Shanghai Mental Health Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this trial is to investigate the efficacy of left DLPFC iTBS in a population of alcohol use disorder patients, compared with the sham iTBS. Moreover, this trial will conduct follow-up assessments to evaluate whether its efficacy can sustain for a long time if it is effective.
Detailed description
Alcohol abuse and alcohol use disorder are important major health issues in our modern society. However, the treatment of alcohol addiction is currently limited to the treatment of acute withdrawal symptoms, but lacks effective interventions to reduce craving and prevent relapse. In an attempt to improve the treatment of substance dependence, non-invasive neuromodulation has gained attention as a new potential treatment option. The aim of this trial is to investigate the efficacy of left DLPFC iTBS in a population of alcohol use disorder patients, compared with the sham iTBS. Moreover, this trial will conduct follow-up assessments to evaluate whether its efficacy can sustain for a long time if it is effective.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Intermittent Theta Burst Stimulation (iTBS) | The target is left DLPFC and the iTBS protocol is: 70% of RMT; triplet 50 Hz bursts, repeated at 5 Hz; 2s on and 8s off; 600 pulses a session. |
| DEVICE | Sham stimulation | The target is right DLPFC and the sham stimulation protocol is: triplet 50 Hz bursts, repeated at 5 Hz; 2s on and 8s off; 600 pulses a session. |
Timeline
- Start date
- 2019-12-06
- Primary completion
- 2020-12-01
- Completion
- 2021-03-01
- First posted
- 2019-04-30
- Last updated
- 2020-03-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03932149. Inclusion in this directory is not an endorsement.